Cargando…
Circulating Tumor Cells as a Tool for Assessing Tumor Heterogeneity
Tumor heterogeneity is the major cause of failure in cancer prognosis and prediction. Accurately detecting heterogeneity for the development of biomarkers and the detection of the clones resistant to therapy is one of the main goals of contemporary medicine. Metastases belong to the natural history...
Autores principales: | Tellez-Gabriel, Marta, Heymann, Marie-Françoise, Heymann, Dominique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643448/ https://www.ncbi.nlm.nih.gov/pubmed/31367241 http://dx.doi.org/10.7150/thno.34337 |
Ejemplares similares
-
Circulating Tumor Cell-Derived Pre-Clinical Models for Personalized Medicine
por: Tellez-Gabriel, Marta, et al.
Publicado: (2018) -
The Challenges of Detecting Circulating Tumor Cells in Sarcoma
por: Tellez-Gabriel, Marta, et al.
Publicado: (2016) -
Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis
por: Tellez-Gabriel, Marta, et al.
Publicado: (2016) -
Isolation of circulating tumor cells in a preclinical model of osteosarcoma: Effect of chemotherapy
por: Chalopin, Antoine, et al.
Publicado: (2018) -
Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers
por: Ségaliny, Aude I., et al.
Publicado: (2015)